Measles, Mumps and Rubella (MMR) Vaccines Market Challenges, opportunities, Key Regions reports, Drivers, key segment and Company Forecast 2018 – 2026

                                                                                  
Vaccines for measles, mumps, and rubella (MMR) are a mix of live viruses that are injected. While the immune system fights and protects against the infection, the live viruses are rendered inactive and unable to multiply in human cells.

Measles, Mumps and Rubella (MMR) Vaccines Market


Vaccines for measles, mumps, and rubella (MMR) are a mix of live viruses that are injected. While the immune system fights and protects against the infection, the live viruses are rendered inactive and unable to multiply in human cells. The MMR vaccine is effective for a long time. The MMR vaccine causes fever, rash, cough, bodily pain, headache, nausea, and serious side effects such as infection of the ovaries and testicles, deafness, and death in rare cases.

The global Measles, Mumps, and Rubella (MMR) Vaccines Market is being driven by an increase in the number of cases and prevalence of the disease. In many regions of the world, the disease is widespread. According to a 2014 report by the Centers for Disease Control and Prevention (CDC), 667 cases were documented in the United States from 27 states.

MMR vaccine development is being funded by both government and non-government organisations. The majority of persons who have not been immunised are infected with MMR. In addition, to prevent the disease from spreading, the Asia-Pacific area is developing awareness programmes and campaigns. Furthermore, the industry is predicted to rise due to strong regulations and patient safety. The government is working on eradicating the disease on a massive scale in order to have a long-term impact.

Market Segmentation:

By Product Type:
  • Monovalent
  • Combinational
  • Divalent
  • Trivalent
  • Others

By End Users:
  • Hospitals
  • Healthcare Centers
  • Others
The major manufacturers with WHO prequalified measles, mumps, and rubella vaccines are GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India Ltd, among others.

Comments

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.